BeStock  
Stocks › Biotechnology › ALMS

Alumis ALMS

US equityMarket cap rank #3572Biotechnology
$3.96 −$0.37 (-8.55%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $4.03 +1.77%
Open$4.24
Prev close$4.33
Day range$3.94 – $4.37
Volume1.79M
Market cap$514.09M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership96.0%-0.84 pts vs. prior quarter
Institutions holding241-3 vs. prior quarter
Insider trades (recent)35 buys / 15 sellsNet buying
Short interest8.52% of floatDays to cover 5.8 · as of 30 Oct 2026
Short-sale volume share14.1%5-day average of daily volume

Short-sale volume as % of daily volume

7%14%21%29%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$10.94M (3 inflow days, 17 outflow days).

Net flow by order size, last 20 sessions

−$7.9MSuper−$3.0MBig−$1.9MMid−$3.3MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 40.7% of shares outstanding.

Largest holders

  • Matrix Capital Management Company, LP11.70%
  • Foresite Capital Management, LLC11.60%
  • BlackRock6.63%
  • Samsara BioCapital LLC5.59%
  • FMR5.23%
  • Deep Track Capital, LP4.90%
  • T. Rowe Price Group, Inc.4.02%
  • venBio LLC3.50%

By investor type

  • VC/PE Fund34.53%
  • Mutual Fund30.01%
  • Hedge Fund26.37%
  • Public Company3.86%
  • Private Company0.70%
  • Individual/Insider0.54%
  • Government Pension Fund0.21%
  • Insurance Company0.17%

Reported short interest has risen from 4.52% to 8.52% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Morgan Stanley Public Company 2026/Q3 +1,843,427 1.7%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +1,843,427 1.7%
Citigroup Inc. Public Company 2026/Q3 +835,251 0.9%
State Street Global Advisors Mutual Fund 2026/Q3 +761,043 2.3%
Pictet Asset Management Limited Mutual Fund 2026/Q3 +636,875 0.5%
Kera Capital Partners, Inc. Family Office/Trust 2026/Q3 +403,818 0.3%
Jane Street Group, LLC Private Company 2026/Q3 +376,825 0.3%
BlackRock Mutual Fund 2026/Q3 +360,253 6.6%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +322,091 0.3%
Barclays PLC Public Company 2026/Q3 +278,586 0.3%
First Trust Advisors L.P. Mutual Fund 2026/Q3 +230,265 0.2%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +158,746 0.2%
Samsara BioCapital LLC VC/PE Fund 2026/Q3 +890,590 5.6%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +158,746 0.2%
FMR Mutual Fund 2026/Q3 +5,795,331 5.2%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
1 Nov 2026 Roy Hardiman Chief Business & Strategy Officer Open Market Disposition -652 $6.52 194,261
1 Nov 2026 John Schroer Chief Financial Officer Open Market Disposition -794 $6.52 4,674
1 Nov 2026 David Goldstein Chief Scientific Officer Open Market Disposition -629 $6.52 229,009
1 Nov 2026 Jorn Drappa Chief Medical Officer & Head of Research and Development Open Market Disposition -593 $6.52 38,802
1 Nov 2026 Sanam Pangali Chief Legal Officer Open Market Disposition -332 $6.52 2,540
1 Nov 2026 Mark Bradley Chief Development Officer Open Market Disposition -623 $6.52 69,571
7 Sep 2026 Samsara BioCapital LLC Open Market Disposition -96,131 $10.55 7,235,809
7 Sep 2026 Samsara BioCapital LLC Open Market Acquisition +986,721 $11.17 7,235,809
2 Aug 2026 Roy Hardiman Chief Business & Strategy Officer Open Market Disposition -2,692 $26.37 195,496
2 Aug 2026 John Schroer Chief Financial Officer Open Market Disposition -3,282 $26.37 3,718
2 Aug 2026 David Goldstein Chief Scientific Officer Open Market Disposition -2,596 $26.37 230,201
2 Aug 2026 Jorn Drappa Chief Medical Officer & Head of Research and Development Open Market Disposition -2,447 $26.37 39,925
2 Aug 2026 Sanam Pangali Chief Legal Officer Open Market Disposition -1,364 $26.37 3,080
2 Aug 2026 Mark Bradley Chief Development Officer Open Market Disposition -2,572 $26.37 70,752
5 Jul 2026 Sanam Pangali Chief Legal Officer Derivative Exercise and Sale -5,000 $28.00 1,111
29 Jun 2026 Srinivas Akkaraju Independent Director Other Acquisition +3,553 – 3,553
29 Jun 2026 Srinivas Akkaraju Independent Director Other Derivative Acquisition +15,528 $28.14 15,528
29 Jun 2026 Sapna Srivastava Lead Independent Director Other Acquisition +3,553 – 3,553
29 Jun 2026 Sapna Srivastava Lead Independent Director Other Derivative Acquisition +15,528 $28.14 15,528
29 Jun 2026 Lynn Tetrault Independent Director Other Acquisition +3,553 – 3,553

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 11,032,098 8.5% 5.8
15 Oct 2026 11,079,936 8.6% 4.9
30 Sep 2026 10,295,705 8.0% 3.6
15 Sep 2026 6,299,106 4.9% 1.0
31 Aug 2026 5,645,753 4.4% 7.1
14 Aug 2026 5,853,901 4.5% 6.5

Discussion

No comments yet — be the first to weigh in on ALMS.

Sign in to join the discussion.

Scroll to Top